We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-5%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.45B
AUM Growth
+$12.9M
(+0.9%)
Cap. Flow
+$99.9M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
34.13%
Holding
1,140
New
132
Increased
492
Reduced
188
Closed
50
Avg Time Held
2.9
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$23.9M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$18.8M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$14.2M |
| 4 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$13.4M |
| 5 |
Apple
AAPL
|
+$6.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$24.4M |
| 2 |
iShares Gold Trust
IAU
|
+$8.75M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.91M |
| 4 |
Ally Financial
ALLY
|
+$4.53M |
| 5 |
Newmont
NEM
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.9% |
| 2 | Technology | 6.89% |
| 3 | Healthcare | 4.85% |
| 4 | Financials | 4% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
AbbVie
ABBV
$504B
| $595K | 0.04% |
4,435
-118
| -3% | -$16.9K |
2013 Q3
36 quarters
|
|
252
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$177M
| $590K | 0.04% |
20,705
+8,105
| +64% | +$259K |
2021 Q2
5 quarters
|
|
253
Philip Morris
PM
$320B
| $585K | 0.04% |
7,044
+37
| +0.5% | +$3.53K |
2013 Q2
37 quarters
|
|
254
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $582K | 0.04% |
15,190
+8,478
| +126% | +$345K |
2018 Q1
18 quarters
|
|
255
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $581K | 0.04% |
15,910
+10,038
| +171% | +$408K |
2013 Q2
37 quarters
|
|
256
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $580K | 0.04% |
6,043
+345
| +6% | +$36.9K |
2013 Q4
35 quarters
|
|
257
DuPont de Nemours
DD
$17.6B
| $572K | 0.04% |
9,034
+263
| +3% | +$18.8K |
2013 Q4
35 quarters
|
|
258
iShares International Select Dividend ETF
IDV
$8.32B
| $563K | 0.04% |
25,001
+10,552
| +73% | +$278K |
2018 Q1
18 quarters
|
|
259
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.1B
| $559K | 0.04% |
30,046
+11,600
| +63% | +$240K |
2020 Q1
10 quarters
|
|
260
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.3B
| $550K | 0.04% |
14,075
+13,178
| +1,469% | +$581K |
2022 Q2
1 quarter
|
|
261
Northern Trust STOXX US ESG Select ETF
ESG
$136M
| $546K | 0.04% |
6,350
+1,154
| +22% | +$110K |
2020 Q1
10 quarters
|
|
262
iShares Russell 2000 Growth ETF
IWO
$13.4B
| $546K | 0.04% |
2,643
+281
| +12% | +$63.2K |
2013 Q4
35 quarters
|
|
263
Watsco Inc
WSO
$12.2B
| $536K | 0.04% |
2,080
| – | – |
2013 Q2
37 quarters
|
|
264
Global X S&P 500 Covered Call ETF
XYLD
$3.41B
| $536K | 0.04% |
14,065
-746
| -5% | -$31.6K |
2022 Q2
1 quarter
|
|
265
Altria Group
MO
$125B
| $531K | 0.04% |
13,154
+3
| +0% | +$131 |
2013 Q2
37 quarters
|
|
266
Meta Platforms (Facebook)
META
$1.81T
| $519K | 0.04% |
3,830
-40
| -1% | -$6.48K |
2013 Q2
37 quarters
|
|
267
iShares Global REIT ETF
REET
$4.68B
| $510K | 0.04% |
23,975
+3,335
| +16% | +$82.2K |
2020 Q4
7 quarters
|
|
268
WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund
AGZD
$151M
| $503K | 0.03% |
+22,070
| New | +$506K |
2022 Q3
0 quarters
|
|
269
Vanguard Real Estate ETF
VNQ
$36.8B
| $496K | 0.03% |
6,186
-5
| -0.1% | -$468 |
2013 Q2
37 quarters
|
|
270
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
| $493K | 0.03% |
3,733
+1,721
| +86% | +$241K |
2019 Q1
14 quarters
|
|
271
West Pharmaceutical
WST
$27B
| $488K | 0.03% |
1,985
-601
| -23% | -$183K |
2020 Q1
10 quarters
|
|
272
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
| $487K | 0.03% |
3,830
| – | – |
2017 Q1
22 quarters
|
|
273
Schwab International Small-Cap Equity ETF
SCHC
$5.49B
| $479K | 0.03% |
17,260
+270
| +2% | +$8.51K |
2020 Q2
9 quarters
|
|
274
Texas Instruments
TXN
$252B
| $477K | 0.03% |
3,086
+597
| +24% | +$100K |
2013 Q3
36 quarters
|
|
275
FT Vest Fund of Buffer ETFs
BUFR
$10.8B
| $474K | 0.03% |
22,754
+11,461
| +101% | +$255K |
2021 Q2
5 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Analysts LLC held 1,140 positions worth $1.45B, up 0.9% from $1.44B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Analysts LLC deployed $99.9M of net new capital in Q3 2022, opening 132 new positions and adding to 492 existing holdings. Its largest new stake was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $24.4M trimmed.
- Capital Analysts LLC's largest Q3 2022 buy was Fidelity MSCI Health Care Index ETF: 64,153 shares worth $3.7M.
- Capital Analysts LLC added most to JPMorgan Ultra-Short Income ETF in Q3 2022, an estimated $23.9M increase.
- Capital Analysts LLC's biggest Q3 2022 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $24.4M.
- Capital Analysts LLC fully exited Ally Financial in Q3 2022, selling an estimated $4.53M.
- Capital Analysts LLC's ten largest holdings make up 34% of its $1.45B portfolio in Q3 2022.
- Capital Analysts LLC opened 132 new positions and closed 50 in Q3 2022.
- Capital Analysts LLC's portfolio value rose 0.9% quarter-over-quarter to $1.45B.
Based on Capital Analysts LLC's 13F filing for Q3 2022, filed 14 Nov 2022.